Published in Nature on April 30, 2008
RNA and disease. Cell (2009) 7.98
Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science (2009) 3.62
Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci U S A (2010) 3.58
CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron (2013) 2.94
The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature (2012) 2.94
Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci (2008) 2.63
Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet (2010) 2.36
Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans (2009) 2.32
RNA-mediated neurodegeneration in repeat expansion disorders. Ann Neurol (2010) 2.30
RNA phase transitions in repeat expansion disorders. Nature (2017) 2.11
Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. J Am Chem Soc (2009) 2.06
Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum Mol Genet (2011) 2.05
Advances in understanding the molecular basis of FXTAS. Hum Mol Genet (2010) 1.83
Rational and modular design of potent ligands targeting the RNA that causes myotonic dystrophy 2. ACS Chem Biol (2009) 1.83
Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucleic Acids Res (2011) 1.77
Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum Mol Genet (2011) 1.72
Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain (2009) 1.66
SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Neuron (2010) 1.56
Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Hum Mol Genet (2009) 1.54
Controlling the specificity of modularly assembled small molecules for RNA via ligand module spacing: targeting the RNAs that cause myotonic muscular dystrophy. J Am Chem Soc (2009) 1.54
Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol (2008) 1.53
Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching. J Am Chem Soc (2012) 1.44
Neurodegeneration the RNA way. Prog Neurobiol (2011) 1.43
Toward understanding Machado-Joseph disease. Prog Neurobiol (2011) 1.42
CAG repeats mimic CUG repeats in the misregulation of alternative splicing. Nucleic Acids Res (2011) 1.42
Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks. Nucleic Acids Res (2012) 1.38
Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease. PLoS One (2008) 1.34
Drosophila melanogaster in the study of human neurodegeneration. CNS Neurol Disord Drug Targets (2010) 1.33
Structural diversity of triplet repeat RNAs. J Biol Chem (2010) 1.29
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res (2011) 1.29
Repeat associated non-ATG translation initiation: one DNA, two transcripts, seven reading frames, potentially nine toxic entities! PLoS Genet (2011) 1.25
A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genet (2012) 1.20
Atomic resolution structure of CAG RNA repeats: structural insights and implications for the trinucleotide repeat expansion diseases. Nucleic Acids Res (2010) 1.18
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome. Future Neurol (2009) 1.17
Long tract of untranslated CAG repeats is deleterious in transgenic mice. PLoS One (2011) 1.16
PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats. PLoS One (2011) 1.12
RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity. Brain Res (2012) 1.11
Huntington's Disease. Cold Spring Harb Perspect Biol (2011) 1.11
Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders. Curr Opin Genet Dev (2014) 1.06
Chemical correction of pre-mRNA splicing defects associated with sequestration of muscleblind-like 1 protein by expanded r(CAG)-containing transcripts. ACS Chem Biol (2012) 1.05
CAG expansion induces nucleolar stress in polyglutamine diseases. Proc Natl Acad Sci U S A (2012) 1.05
Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis. Neurobiol Dis (2010) 1.02
Pathogenic RNAs in microsatellite expansion disease. Neurosci Lett (2009) 1.01
The role of CELF proteins in neurological disorders. RNA Biol (2010) 1.00
Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO Mol Med (2009) 1.00
Mutation of a U2 snRNA gene causes global disruption of alternative splicing and neurodegeneration. Cell (2012) 1.00
Membrane trafficking in neuronal maintenance and degeneration. Cell Mol Life Sci (2012) 0.99
Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex. Nat Commun (2013) 0.99
Non-coding RNA in neural function, disease, and aging. Front Genet (2015) 0.97
Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice. Dis Model Mech (2009) 0.97
CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders. RNA Biol (2011) 0.97
Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3. Hum Mol Genet (2009) 0.96
Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy. PLoS Genet (2011) 0.95
Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS. J Mol Neurosci (2011) 0.95
RNA toxicity in polyglutamine disorders: concepts, models, and progress of research. J Mol Med (Berl) (2013) 0.94
Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice. Mol Ther (2013) 0.94
Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome. J Investig Med (2009) 0.93
Genes and pathways affected by CAG-repeat RNA-based toxicity in Drosophila. Hum Mol Genet (2011) 0.91
An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases. BMC Mol Biol (2012) 0.91
A fruitful endeavor: modeling ALS in the fruit fly. Brain Res (2014) 0.91
Mechanisms of RNA-induced toxicity in CAG repeat disorders. Cell Death Dis (2013) 0.91
Oligonucleotide-based strategies to combat polyglutamine diseases. Nucleic Acids Res (2014) 0.90
Perturbation of the Akt/Gsk3-β signalling pathway is common to Drosophila expressing expanded untranslated CAG, CUG and AUUCU repeat RNAs. Hum Mol Genet (2011) 0.90
RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond. Wiley Interdiscip Rev RNA (2011) 0.90
Animal models of polyglutamine diseases and therapeutic approaches. J Biol Chem (2008) 0.90
Impact of age-associated increase in 2'-O-methylation of miRNAs on aging and neurodegeneration in Drosophila. Genes Dev (2014) 0.88
Pathogenic polyglutamine proteins cause dendrite defects associated with specific actin cytoskeletal alterations in Drosophila. Proc Natl Acad Sci U S A (2011) 0.87
Recent advances in using Drosophila to model neurodegenerative diseases. Apoptosis (2009) 0.86
Epigenetics in nucleotide repeat expansion disorders. Semin Neurol (2012) 0.85
Large-scale screen for modifiers of ataxin-3-derived polyglutamine-induced toxicity in Drosophila. PLoS One (2012) 0.85
SCA8 CAG/CTG expansions, a tale of two TOXICities: a unique or common case? PLoS Genet (2009) 0.85
Defining genetic factors that modulate intergenerational CAG repeat instability in Drosophila melanogaster. Genetics (2010) 0.85
The role of the immune system in triplet repeat expansion diseases. Mediators Inflamm (2015) 0.85
A dynamic structural model of expanded RNA CAG repeats: a refined X-ray structure and computational investigations using molecular dynamics and umbrella sampling simulations. J Am Chem Soc (2013) 0.84
Drosophila as an In Vivo Model for Human Neurodegenerative Disease. Genetics (2015) 0.83
RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders. Nucleic Acids Res (2014) 0.83
RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis. Front Cell Neurosci (2014) 0.82
Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity. Proc Natl Acad Sci U S A (2009) 0.82
Genetic complexity in a Drosophila model of diabetes-associated misfolded human proinsulin. Genetics (2013) 0.82
Therapeutic prospects for spinocerebellar ataxia type 2 and 3. Drugs Future (2009) 0.82
Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65. Sci Rep (2015) 0.82
Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases. Front Mol Neurosci (2013) 0.81
Polyglutamine repeats are associated to specific sequence biases that are conserved among eukaryotes. PLoS One (2012) 0.81
GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function. Elife (2015) 0.81
RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases. Front Mol Neurosci (2013) 0.81
Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies. Mol Neurobiol (2013) 0.81
Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene. Curr Genomics (2008) 0.80
The hnRNP-Htt axis regulates necrotic cell death induced by transcriptional repression through impaired RNA splicing. Cell Death Dis (2016) 0.80
Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders. Exp Neurol (2012) 0.79
Structural studies of CNG repeats. Nucleic Acids Res (2014) 0.78
Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases. Hum Mol Genet (2013) 0.78
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease. Hum Mol Genet (2016) 0.78
Identification of genes in toxicity pathways of trinucleotide-repeat RNA in C. elegans. Nat Struct Mol Biol (2014) 0.78
Ubiquitous expression of CUG or CAG trinucleotide repeat RNA causes common morphological defects in a Drosophila model of RNA-mediated pathology. PLoS One (2012) 0.78
Diced triplets expose neurons to RISC. PLoS Genet (2012) 0.78
Structural Insights Reveal the Dynamics of the Repeating r(CAG) Transcript Found in Huntington's Disease (HD) and Spinocerebellar Ataxias (SCAs). PLoS One (2015) 0.77
Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells. World J Stem Cells (2015) 0.77
RNA-binding protein misregulation in microsatellite expansion disorders. Adv Exp Med Biol (2014) 0.77
Muscling in: Gene therapies for muscular dystrophy target RNA. Nat Med (2010) 0.77
Pulling complexes out of complex diseases: Spinocerebellar Ataxia 7. Rare Dis (2014) 0.77
Trinucleotide repeat disorders. Annu Rev Neurosci (2007) 9.45
Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science (1998) 6.67
Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J (2000) 6.56
Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell (1998) 6.24
Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet (2005) 4.66
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell (2006) 4.53
RNA-mediated neuromuscular disorders. Annu Rev Neurosci (2006) 4.24
Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell (1998) 4.07
Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol Cell (2005) 4.07
Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet (2006) 3.87
Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell (2001) 3.29
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet (2001) 3.27
Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet (2004) 3.21
Opinion: What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol (2005) 3.18
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A (2006) 3.09
RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron (2003) 2.81
CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. Science (2007) 2.45
Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron (2003) 2.39
Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J Cell Sci (2005) 2.31
Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Hum Mol Genet (2004) 2.23
Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum Mol Genet (2000) 2.04
muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development (1997) 2.02
Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol (2007) 1.91
Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol Cell (2005) 1.84
The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev Biol (1998) 1.71
A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci (2004) 1.45
Pathogenic RNA repeats: an expanding role in genetic disease. Trends Genet (2004) 1.30
The pathogenic agent in Drosophila models of 'polyglutamine' diseases. Hum Mol Genet (2005) 1.06
Biomedicine. Reconstructing myotonic dystrophy. Science (2001) 0.99
Generation of GAL4-responsive muscleblind constructs. Genesis (2002) 0.91
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science (2006) 7.72
Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science (2001) 6.15
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature (2010) 5.26
Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron (2003) 4.04
Biochemical and pathological characterization of Lrrk2. Ann Neurol (2006) 3.14
The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature (2012) 2.94
RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc Natl Acad Sci U S A (2008) 2.76
A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A (2011) 2.68
Drosophila as a model for human neurodegenerative disease. Annu Rev Genet (2005) 2.63
MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell (2006) 2.55
Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr Biol (2005) 2.35
Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc Natl Acad Sci U S A (2006) 1.88
Maintaining the brain: insight into human neurodegeneration from Drosophila melanogaster mutants. Nat Rev Genet (2009) 1.84
Pharmacological prevention of Parkinson disease in Drosophila. Nat Med (2002) 1.84
Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol Cell (2005) 1.84
Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet (2007) 1.66
Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet (2012) 1.62
Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila. J Biol Chem (2004) 1.60
The exoribonuclease Nibbler controls 3' end processing of microRNAs in Drosophila. Curr Biol (2011) 1.56
A novel Drosophila model of nerve injury reveals an essential role of Nmnat in maintaining axonal integrity. Curr Biol (2012) 1.51
DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc Natl Acad Sci U S A (2010) 1.49
An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J (2006) 1.45
MicroRNAs and neurodegeneration: role and impact. Trends Cell Biol (2012) 1.38
Polyglutamine genes interact to modulate the severity and progression of neurodegeneration in Drosophila. PLoS Biol (2008) 1.33
Roles of trinucleotide-repeat RNA in neurological disease and degeneration. Trends Neurosci (2010) 1.30
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum Mol Genet (2011) 1.24
A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem (2008) 1.23
A new role for microRNA pathways: modulation of degeneration induced by pathogenic human disease proteins. Cell Cycle (2006) 1.13
Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies. Am J Pathol (2006) 1.13
PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats. PLoS One (2011) 1.12
Axon degeneration and regeneration: insights from Drosophila models of nerve injury. Annu Rev Cell Dev Biol (2012) 1.10
Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum Mol Genet (2002) 1.09
DJ-1 is present in a large molecular complex in human brain tissue and interacts with alpha-synuclein. J Neurochem (2005) 1.08
Design and implementation of in vivo imaging of neural injury responses in the adult Drosophila wing. Nat Protoc (2013) 0.98
Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model. PLoS Genet (2013) 0.97
Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3. Hum Mol Genet (2009) 0.96
Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy. PLoS Genet (2011) 0.95
Genes and pathways affected by CAG-repeat RNA-based toxicity in Drosophila. Hum Mol Genet (2011) 0.91
Impact of age-associated increase in 2'-O-methylation of miRNAs on aging and neurodegeneration in Drosophila. Genes Dev (2014) 0.88
The exonuclease Nibbler regulates age-associated traits and modulates piRNA length in Drosophila. Aging Cell (2015) 0.87
Suppression of polyglutamine toxicity by the yeast Sup35 prion domain in Drosophila. J Biol Chem (2007) 0.87
Modeling human trinucleotide repeat diseases in Drosophila. Int Rev Neurobiol (2011) 0.86
Defining genetic factors that modulate intergenerational CAG repeat instability in Drosophila melanogaster. Genetics (2010) 0.85
Identification of genes involved in biosynthesis of mannan polysaccharides in Dendrobium officinale by RNA-seq analysis. Plant Mol Biol (2015) 0.85
Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in Drosophila. Hum Mol Genet (2011) 0.84
Cell biology. Yeast informs Alzheimer's disease. Science (2011) 0.79
Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72. J Neuropathol Exp Neurol (2014) 0.78
Abnormal mesenchymal differentiation in the superior semicircular canal of brn4/pou3f4 knockout mice. Arch Otolaryngol Head Neck Surg (2005) 0.78
Hosting neurotoxicity in polyglutamine disease. Cell (2006) 0.77
Drosophila models of polyglutamine diseases. Methods Mol Biol (2003) 0.76
Development and Validation of Targeted Next-Generation Sequencing Panels for Detection of Germline Variants in Inherited Diseases. Arch Pathol Lab Med (2017) 0.75
Blind polarization demultiplexing by constructing a cost function for coherent optical PDM-OFDM. Opt Express (2015) 0.75